Health

Steve Jobs and Why Pancreatic Cancer is SO Deadly

Posted on
Share

Apple’s Steve Job had a pancreatic neuroendocrine tumor. Apple Inc. announced his death Wednesday

As we all know, Apple, Inc’s CEO Steve Jobs passed away last night from cancer.

What kind of cancer did Jobs have and why was it so deadly for such a young individual?

As the technology world mourns computing visionary and Apple, Inc. co-founder Steve Jobs, it’s worth taking a closer look at the disease he publicly battled.

Jobs had a rare form of pancreatic cancer called a neuroendocrine tumor. Patrick Swayze, Joan Crawford, Margaret Mead and Luciano Pavarotti all died from a more common form of pancreatic cancer, called adenocarcinoma. Supreme Court Justice Ruth Bader Ginsburg underwent surgery for pancreatic cancer in February 2009 and, 18 days later, returned to the bench.

“Right now, pancreatic cancer is getting publicity, but it’s a neglected disease,” said Dr. Michaela Banck, medical oncologist at the Mayo Clinic, who treats patients with neuroendocrine tumors. “It doesn’t draw the same attention as colon cancer and breast cancer. Activist groups raise small amounts of money, since it’s a rare disease. It’s a complicated disease. We don’t have enough money to make progress as fast as we’d like to.”

Pancreatic cancer is the fourth-leading cause of death from cancer in the United States, after lung, colon and breast cancer. The lifetime risk of developing it is about 1 in 71. This year, about 44,030 people will be diagnosed with pancreatic cancer, and the disease will kill about 37,660 people, according to the American Cancer Society.

About 95 percent of people with pancreatic cancer die from it, experts say. It’s so lethal because during the early stages, when the tumor would be most treatable, there are usually no symptoms. It tends to be discovered at advanced stages when abdominal pain or jaundice may result. Presently, there are no general screening tools […]

Researchers are working on better understanding the way in which pancreatic tumors grow and spread, Libutti said.

“There are a number of agents that are being looked at in clinical trials that focus on pathways that may allow pancreatic cancer to evade normal processes,” Libutti said.

One is an antibody that blocks a particular protein called PD-1 on the surface of pancreatic cancer, meaning chemotherapies would be more effective because there would be an enhanced immune response against the tumor. That work is being done by the National Cancer Institute.

Libutti’s lab is working on targeted nanoparticle therapies for metastatic neuroendocrine tumors. The idea is that tiny particles are coated with material that hones in on tumor cells and delivers drugs to kill them without harming healthy tissue, reducing the toxicity to the body in general. This research is still in animal models.

“We’re hopeful that in the not-too-distant future, we’ll be ready to move into clinical trials,” he said.

Another line of research is focused on finding biomarkers of pancreatic cancer so that a simple blood or urine test could be developed. Unlike screenings for other conditions such as colon, breast and prostate cancers, there is no routine way to see whether a patient has a tumor in the pancreas.

The future of medicine to help people with pancreatic cancer will involve genetics, said Banck. This would involve matching a person’s particular type of tumor using genomic information with treatment.

“What’s going to make real difference in the future is the revolution of the genomic era,” she said.

Read it all……

Steve Jobs will be missed.

Share
Health

Smokers Twice as Likely to Have Strokes and Younger Too

Posted on
Share

According to a new study.

Not only are smokers twice as likely to have strokes, they are almost a decade younger than non-smokers when they have them, according to a study presented October 3 at the Canadian Stroke Congress.

Between January 2009 and March 2011, researchers studied 982 stroke patients (264 smokers and 718 non-smokers) at an Ottawa prevention clinic. They found the average age of stroke patients who smoked was 58, compared to age 67 for non-smokers.

“The information from this study provides yet another important piece of evidence about the significance of helping people stop smoking,” said Dr. Andrew Pipe of the University of Ottawa Heart Institute, one of the study’s authors. “It also alerts the neurology community to the importance of addressing smoking in stroke patients.”

Smoking causes a build-up of debris on the inside of blood vessels, a condition called atherosclerosis, and it contributes to a higher likelihood of clots forming, said Dr. Pipe.

The Ottawa Hospital study, led by principal investigators Dr. Mike Sharma and Dr. Robert Reid, found smokers have double the risk of a stroke caused by a dislodged blood clot (ischemic stroke) and four times the risk of a stroke caused by a ruptured blood vessel (hemorrhagic stroke) than the non-smoking population.

In addition, smokers have a greater chance of having more complications and recurrent strokes. Patients who have had a minor stroke are 10 times more likely to have a major stroke, especially if they continue to smoke, said Dr. Pipe.

Stroke is preventable.

So, quit smoking, follow a healthy diet and exercise regularly – for your health’s sake.

Share
Health

Tobacco Companies Knew Cigarettes Contained Radioactive Cancer Causing Particles

Posted on
Share

According to a new paper.

Tobacco companies knew that cigarette smoke contained radioactive alpha particles for more than four decades and developed “deep and intimate” knowledge of these particles’ cancer-causing potential, but they deliberately kept their findings from the public, according to a new study by UCLA researchers.

The analysis of dozens of previously unexamined internal tobacco industry documents, made available in 1998 as the result of a legal settlement, reveals that the industry was aware of cigarette radioactivity some five years earlier than previously thought and that tobacco companies, concerned about the potential lung cancer risk, began in-depth investigations into the possible effects of radioactivity on smokers as early as the 1960s.

“The documents show that the industry was well aware of the presence of a radioactive substance in tobacco as early as 1959,” the authors write. “Furthermore, the industry was not only cognizant of the potential ‘cancerous growth’ in the lungs of regular smokers, but also did quantitative radiobiological calculations to estimate the long-term lung radiation absorption dose of ionizing alpha particles emitted from cigarette smoke.” The study, published online Sept. 27 in Nicotine & Tobacco Research, the peer-reviewed journal of the Society for Research on Nicotine and Tobacco, adds to a growing body of research detailing the industry’s knowledge of cigarette smoke radioactivity and its efforts to suppress that information.

“They knew that the cigarette smoke was radioactive way back then and that it could potentially result in cancer, and they deliberately kept that information under wraps,” said the study’s first author, Hrayr S. Karagueuzian, a professor of cardiology who conducts research at UCLA’s Cardiovascular Research Laboratory, part of the David Geffen School of Medicine at UCLA. “Specifically, we show here that the industry used misleading statements to obfuscate the hazard of ionizing alpha particles to the lungs of smokers and, more importantly, banned any and all publication on tobacco smoke radioactivity.”

The radioactive substance — which the UCLA study shows was first brought to the attention of the tobacco industry in 1959 — was identified in 1964 as the isotope polonium-210, which emits carcinogenic alpha radiation. Polonium-210 can be found in all commercially available domestic and foreign cigarette brands, Karagueuzian said, and is absorbed by tobacco leaves through naturally occurring radon gas in the atmosphere and through high-phosphate chemical fertilizers used by tobacco growers. The substance is eventually inhaled by smokers into the lungs.

The study outlines the industry’s growing concerns about the cancer risk posed by polonium-210 inhalation and the research that industry scientists conducted over the decades to assess the radioactive isotope’s potential effect on smokers — including one study that quantitatively measured the potential lung burden from radiation exposure in a two-pack-a-day smoker over a two-decade period.

The cigarette companies knew about the lung cancer causing radiation, studied it and said nothing. And. despite knowing about the risk to its customers, declined to adopt techniques that could have helped eliminate the polonium-210 from the tobacco.

Despite the potential risk of lung cancer, tobacco companies declined to adopt a technique discovered in 1959 and then another developed in 1980 that could have helped eliminate polonium-210 from tobacco, the researchers said. The 1980 technique, known as an acid-wash, was found to be highly effective in removing the radioisotope from tobacco plants, where it forms a water-insoluble complex with the sticky, hair-like structures called trichomes that cover the leaves.

And while the industry frequently cited concerns over the cost and the possible environmental impact as rationales for not using the acid wash, UCLA researchers uncovered documents that they say indicate the real reason may have been far different.

“The industry was concerned that the acid media would ionize the nicotine, making it more difficult to be absorbed into the brains of smokers and depriving them of that instant nicotine rush that fuels their addiction,” Karagueuzian said. “The industry also were well aware that the curing of the tobacco leaves for more than a one-year period also would not eliminate the polonium-210, which has a half-life of 135 days, from the tobacco leaves because it was derived from its parent, lead-210, which has a half-life of 22 years.”

The Food and Drug Administration under the 2009 Family Smoking Prevention and Tobacco Control Act should force the cigarette companies to cleanse their product of these radioactive isotopes, emitting alpha particles.

Period.

Frankly, I don’t care if their product doesn’t deliver the nicotine kick or keeps their customers addicted. I do care that people are dying needlessly because of lung cancer caused by the product.

Karagueuzian said the earliest causal link between alpha particles and cancer was made in around 1920, when alpha particle-emitting radium paint was used to paint luminescent numbers on watch dials. The painting was done by hand, and the workers commonly used their lips to produce a point on the tip of the paint brush. Many workers accumulated significant burdens of alpha particles through ingestion and absorption of radium-226 into the bones and subsequently developed jaw and mouth cancers. The practice was eventually discontinued.

Another example involves liver cancer in patients exposed to chronic low-dose internal alpha particles emitted from the poorly soluble deposits of thorium dioxide after receiving the contrast agent Thorotrast. It has been suggested that the liver cancers resulted from point mutations of the tumor suppressor gene p53 by the accumulated alpha particles present in the contrast media. The use of Thorotrast as contrast agent was stopped in the 1950s.

Here is the abstract of the paper.

Introduction: To determine the tobacco industry’s policy and action with respect to radioactive polonium 210 (210Po) in cigarette smoke and to assess the long-term risk of lung cancer caused by alpha particle deposits in the lungs of regular smokers.

Methods: Analysis of major tobacco industries’ internal secret documents on cigarette radioactivity made available online by the Master Settlement Agreement in 1998.

Results:
The documents show that the industry was well aware of the presence of a radioactive substance in tobacco as early as 1959. Furthermore, the industry was not only cognizant of the potential “cancerous growth” in the lungs of regular smokers but also did quantitative radiobiological calculations to estimate the long-term (25 years) lung radiation absorption dose (rad) of ionizing alpha particles emitted from the cigarette smoke. Our own calculations of lung rad of alpha particles match closely the rad estimated by the industry. According to the Environmental Protection Agency, the industry’s and our estimate of long-term lung rad of alpha particles causes 120–138 lung cancer deaths per year per 1,000 regular smokers. Acid wash was discovered in 1980 to be highly effectively in removing 210Po from the tobacco leaves; however, the industry avoided its use for concerns that acid media would ionize nicotine converting it into a poorly absorbable form into the brain of smokers thus depriving them of the much sought after instant “nicotine kick” sensation.

Conclusions:
The evidence of lung cancer risk caused by cigarette smoke radioactivity is compelling enough to warrant its removal.

Share
Dentistry

Is There an Association Between Body Mass Index and Periodontal Disease?

Posted on
Share

Yes, according to a new study.

This study evaluated the association between body mass index (BMI) and periodontal condition in a population of Brazilian women. A hospital convenience sample of 594 eligible women was recruited from a women’s health reference center of Belo Horizonte, Brazil. Four groups were formed considering BMI levels: BMI normal group (n = 352), overweight (n = 54), obesity level I (n = 48), obesity level II (n = 56), and obesity level III (n = 74). Full-mouth periodontal examination was performed and biological, demographic, and behavioral risk variables were evaluated. Obese and overweight women showed statistically significant differences in bleeding on probing, probing depth and clinical attachment level ≥4 mm, and frequency of periodontitis (p < 0.05) compared to women showing normal BMI. The final multivariate model for the occurrence of periodontitis revealed that obesity groups were significantly associated with periodontitis. In addition, age (25-45), smoking, diabetes, and hypertension remained significantly associated with the occurrence of periodontitis (p < 0.05). Periodontitis was positively associated with obesity, and this association was more evident as obesity levels increases. These findings indicate the need for early diagnosis and the inclusion of periodontal care in health care programs for obese women.

Periodontal disease is looking like another complication related to obesity.

So, please, watch your diet and exercise regularly.

Your body will really thank you for your diligence.

Share
Health

Does Cessation of Smoking Boost Everyday Memory?

Posted on
Share

Yes, according to the newest research.

Giving up smoking isn’t just good for your health, it’s also good for your memory, according to research from Northumbria University. Research published in this month’s online edition of Drug and Alcohol Dependence reveals that stopping smoking can restore everyday memory to virtually the same level as non-smokers.

Academics from the Collaboration for Drug and Alcohol Research Group at Northumbria University tested 27 smokers, 18 previous smokers and 24 who had never smoked on a real-world memory test.

Participants were asked to remember pre-determined tasks at specific locations on a tour of a university campus. While smokers performed badly, remembering just 59% of tasks, those who had given up smoking remembered 74% of their required tasks compared to those who had never smoked who remembered 81% of tasks.

Dr Tom Heffernan from the Collaboration for Drug and Alcohol Research Group at Northumbria University said: “Given that there are up to 10 million smokers in the UK and as many as 45 million in the United States, it’s important to understand the effects smoking has on everyday cognitive function — of which prospective memory is an excellent example.”

He added: “This is the first time that a study has set out to examine whether giving up smoking has an impact on memory.

“We already know that giving up smoking has huge health benefits for the body but this study also shows how stopping smoking can have knock-on benefits for cognitive function too.”

Another good reason to never start smoking and if you do – QUIT.

Share